Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology

摘要

Objective We developed clinical practice guidelines to assess the individual risk–benefit profile of androgen replacement therapy in adult male hypogonadism (HG), defined by the presence of specific signs and symptoms and serum testosterone (T) below 12nmol/L.